Dr. Hexner is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3400 Spruce St
15 Penn Tower
Philadelphia, PA 19104Phone+1 215-662-3914- Is this information wrong?
Education & Training
- University of Pennsylvania Health SystemFellowship, Hematology and Medical Oncology, 2002 - 2005
- New York Presbyterian Hospital (Cornell Campus)Residency, Internal Medicine, 1999 - 2002
- Columbia University Vagelos College of Physicians and SurgeonsClass of 1999
Certifications & Licensure
- PA State Medical License 2002 - 2024
- American Board of Internal Medicine Hematology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- Correlative Biomarker Study in Patients With Myeloproliferative Disorders Start of enrollment: 2007 Apr 01
- Research Tissue Bank Start of enrollment: 2007 Sep 01
- Umbilical Cord Blood Transplant for Hematological Malignancies Start of enrollment: 2009 Jan 01
- Join now to see all
Publications & Presentations
PubMed
- 116 citationsPegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyureaAbdulraheem Yacoub, John Mascarenhas, Heidi E. Kosiorek, Josef T. Prchal, Dmitriy Berenzon
Blood. 2019-10-31 - 804 citationsCRISPR-engineered T cells in patients with refractory cancerEdward A. Stadtmauer, Joseph A. Fraietta, Megan M. Davis, Adam D. Cohen, Kristy L. Weber
Science. 2020-02-28 - 76 citationsThe clinical benefit of ruxolitinib across patient subgroups: analysis of a placebo-controlled, Phase III study in patients with myelofibrosisSrdan Verstovsek, Ruben A. Mesa, Jason Gotlib, Richard S. Levy, Vikas Gupta
British Journal of Haematology. 2013-05-01
Journal Articles
- CD44: Expanding the toolKITElizabeth Hexner, MD, Blood
- Oral Vancomycin Prophylaxis Is Highly Effective in Preventing Clostridium Difficile Infection in Allogeneic Hematopoietic Cell Transplant RecipientsEdward A Stadtmauer, James K Mangan, Elizabeth O Hexner, David L Porter, Daria V Babushok, Jacqueline Smith, Craig W Freyer, Mindy Schuster, Noelle V Frey, Selina M Lu..., Clinical Infectious Diseases
- Germline Duplication of ATG2B and GSKIP Genes Is Not Required for the Familial Myeloid Malignancy Syndrome Associated with the Duplication of Chromosome 14q32David B Lieberman, Daria V Babushok, Timothy S Olson, Stella T Chou, Elizabeth O Hexner, Nature
Abstracts/Posters
- The MAGIC Algorithm Probability (MAP): A Novel Laboratory Biomarker for the Response to Treatment of Acute Graft-Versus-Host DiseaseElizabeth O. Hexner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- First-in-Human Assessment of Feasibility and Safety of Multiplexed Genetic Engineering of Autologous T Cells Expressing NY-ESO -1 TCR and CRISPR/Cas9 Gene Edited to El...Elizabeth O. Hexner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
- Final Results of Prospective Treatment with Pegylated Interferon Alfa-2a for Patients with Polycythemia Vera and Essential Thrombocythemia in First and Second-Line Set...Elizabeth O. Hexner, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/8/2019
- Join now to see all
Authored Content
- Interleukin-18 Secreting Autologous Anti-CD19 CAR T-cells (huCART19-IL18) in Patients with Non-Hodgkin Lymphomas Relapsed or Refractory to Prior CAR T-cell TherapyDecember 2022
Press Mentions
- 2 Clinical Activity in a Phase 1 Study of Blu-285, a Potent, Highly-Selective Inhibitor of KIT D816V in Advanced Systemic Mastocytosis (AdvSM)December 10th, 2017
Hospital Affiliations
- Hospital of the University of PennsylvaniaPhiladelphia, Pennsylvania
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: